The effects of APOEε4 on tau pathology with the presence of amyloid-β may help explain faster disease progression [9, 40] as well as the stronger relationship between amyloid-β and cognitive decline in APOEε4 carriers [10–12]. The gene discussed is MAPT; the disease is Mental deterioration.